Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis
<p><strong>Purpose</strong></p> <p>To use a novel segmentation methodology based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to define tumour subregions of liver metastases from colorectal cancer (CRC), to compare these with histology, and to use t...
| Päätekijät: | , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Elsevier
2020
|
| _version_ | 1826301402415104000 |
|---|---|
| author | Franklin, JM Irving, B Papiez, BW Kallehaugem JF Wang, LM Goldin, RD Harris, AL Anderson, EM Schnabel, JA Chappell, MA Brady, M Sharma, RA Gleeson, FV |
| author_facet | Franklin, JM Irving, B Papiez, BW Kallehaugem JF Wang, LM Goldin, RD Harris, AL Anderson, EM Schnabel, JA Chappell, MA Brady, M Sharma, RA Gleeson, FV |
| author_sort | Franklin, JM |
| collection | OXFORD |
| description | <p><strong>Purpose</strong></p>
<p>To use a novel segmentation methodology based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to define tumour subregions of liver metastases from colorectal cancer (CRC), to compare these with histology, and to use these to compare extracted pharmacokinetic (PK) parameters between tumour subregions.</p>
<p><strong>Materials and Methods</strong></p>
<p>This ethically-approved prospective study recruited patients with CRC and ≥1 hepatic metastases scheduled for hepatic resection. Patients underwent DCE-MRI pre-metastasectomy. Histological sections of resection specimens were spatially matched to DCE-MRI acquisitions and used to define histological subregions of viable and non-viable tumour. A semi-automated voxel-wise image segmentation algorithm based on the DCE-MRI contrast-uptake curves was used to define imaging subregions of viable and non-viable tumour. Overlap of histologically-defined and imaging subregions was compared using the Dice similarity coefficient (DSC). DCE-MRI PK parameters were compared for the whole tumour and histology-defined and imaging-derived subregions.</p>
<p><strong>Results</strong></p>
<p>Fourteen patients were included in the analysis. Direct histological comparison with imaging was possible in nine patients. Mean DSC for viable tumour subregions defined by imaging and histology was 0.738 (range 0.540-0.930). There were significant differences between K trans and k ep for viable and non-viable subregions (p < 0.001) and between whole lesions and viable subregions (p < 0.001).</p>
<p><strong>Conclusion</strong></p>
<p>We demonstrate good concordance of viable tumour segmentation based on pre-operative DCE-MRI with a post-operative histological gold-standard. This can be used to extract viable tumour-specific values from quantitative image analysis, and could improve treatment response assessment in clinical practice.</p> |
| first_indexed | 2024-03-07T05:31:53Z |
| format | Journal article |
| id | oxford-uuid:e28d0f48-decb-4038-9f6c-92888ab3a81a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:31:53Z |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:e28d0f48-decb-4038-9f6c-92888ab3a81a2022-03-27T10:02:19ZTumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e28d0f48-decb-4038-9f6c-92888ab3a81aEnglishSymplectic ElementsElsevier2020Franklin, JMIrving, BPapiez, BWKallehaugem JFWang, LMGoldin, RDHarris, ALAnderson, EMSchnabel, JAChappell, MABrady, MSharma, RAGleeson, FV<p><strong>Purpose</strong></p> <p>To use a novel segmentation methodology based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to define tumour subregions of liver metastases from colorectal cancer (CRC), to compare these with histology, and to use these to compare extracted pharmacokinetic (PK) parameters between tumour subregions.</p> <p><strong>Materials and Methods</strong></p> <p>This ethically-approved prospective study recruited patients with CRC and ≥1 hepatic metastases scheduled for hepatic resection. Patients underwent DCE-MRI pre-metastasectomy. Histological sections of resection specimens were spatially matched to DCE-MRI acquisitions and used to define histological subregions of viable and non-viable tumour. A semi-automated voxel-wise image segmentation algorithm based on the DCE-MRI contrast-uptake curves was used to define imaging subregions of viable and non-viable tumour. Overlap of histologically-defined and imaging subregions was compared using the Dice similarity coefficient (DSC). DCE-MRI PK parameters were compared for the whole tumour and histology-defined and imaging-derived subregions.</p> <p><strong>Results</strong></p> <p>Fourteen patients were included in the analysis. Direct histological comparison with imaging was possible in nine patients. Mean DSC for viable tumour subregions defined by imaging and histology was 0.738 (range 0.540-0.930). There were significant differences between K trans and k ep for viable and non-viable subregions (p < 0.001) and between whole lesions and viable subregions (p < 0.001).</p> <p><strong>Conclusion</strong></p> <p>We demonstrate good concordance of viable tumour segmentation based on pre-operative DCE-MRI with a post-operative histological gold-standard. This can be used to extract viable tumour-specific values from quantitative image analysis, and could improve treatment response assessment in clinical practice.</p> |
| spellingShingle | Franklin, JM Irving, B Papiez, BW Kallehaugem JF Wang, LM Goldin, RD Harris, AL Anderson, EM Schnabel, JA Chappell, MA Brady, M Sharma, RA Gleeson, FV Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| title | Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| title_full | Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| title_fullStr | Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| title_full_unstemmed | Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| title_short | Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| title_sort | tumour subregion analysis of colorectal liver metastases using semi automated clustering based on dce mri comparison with histological subregions and impact on pharmacokinetic parameter analysis |
| work_keys_str_mv | AT franklinjm tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT irvingb tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT papiezbw tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT kallehaugemjf tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT wanglm tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT goldinrd tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT harrisal tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT andersonem tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT schnabelja tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT chappellma tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT bradym tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT sharmara tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis AT gleesonfv tumoursubregionanalysisofcolorectallivermetastasesusingsemiautomatedclusteringbasedondcemricomparisonwithhistologicalsubregionsandimpactonpharmacokineticparameteranalysis |